Abstract

Cardiac arrhythmias are a primary contributor to sudden cardiac death, a major unmet medical need. Because right ventricular (RV) dysfunction increases the risk for sudden cardiac death, we examined responses to RV stress in mice. Among immune cells accumulated in the RV after pressure overload-induced by pulmonary artery banding, interfering with macrophages caused sudden death from severe arrhythmias. We show that cardiac macrophages crucially maintain cardiac impulse conduction by facilitating myocardial intercellular communication through gap junctions. Amphiregulin (AREG) produced by cardiac macrophages is a key mediator that controls connexin 43 phosphorylation and translocation in cardiomyocytes. Deletion of Areg from macrophages led to disorganization of gap junctions and, in turn, lethal arrhythmias during acute stresses, including RV pressure overload and β-adrenergic receptor stimulation. These results suggest that AREG from cardiac resident macrophages is a critical regulator of cardiac impulse conduction and may be a useful therapeutic target for the prevention of sudden death.

Cardiac immune cells play various roles in the maintenance of homeostasis and diseases in the heart. Here the authors show that cardiac resident macrophages are a critical regulator of cardiac impulse conduction through amphiregulin production, contributing to the prevention of sudden death.

Details

Title
Cardiac macrophages prevent sudden death during heart stress
Author
Sugita Junichi 1 ; Fujiu Katsuhito 2   VIAFID ORCID Logo  ; Nakayama Yukiteru 1   VIAFID ORCID Logo  ; Matsubara Takumi 1 ; Matsuda, Jun 1   VIAFID ORCID Logo  ; Oshima Tsukasa 1 ; Liu, Yuxiang 1 ; Maru Yujin 1 ; Hasumi Eriko 1   VIAFID ORCID Logo  ; Kojima Toshiya 1 ; Seno, Hiroshi 3 ; Asano Keisuke 3 ; Ishijima Ayumu 3 ; Tomii Naoki 3 ; Yamazaki Masatoshi 3 ; Kudo Fujimi 4 ; Sakuma Ichiro 3 ; Nagai Ryozo 5 ; Manabe Ichiro 4 ; Komuro Issei 1   VIAFID ORCID Logo 

 Department of Cardiovascular Medicine, the University of Tokyo, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Department of Cardiovascular Medicine, the University of Tokyo, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Department of Advanced Cardiology, the University of Tokyo, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); PRESTO, Japan Science and Technology Agency, Saitama, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200) 
 The University of Tokyo, Medical Device Development and Regulation Research Center, Department of Bioengineering/Department of Precision Engineering, School of Engineering, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 Chiba University, Department of Disease Biology and Molecular Medicine, Graduate School of Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101) 
 Jichi Medical University, Tochigi, Japan (GRID:grid.410804.9) (ISNI:0000000123090000) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2505573876
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.